Delivery Order SPE2DB22D1017-SPE2DB25FE8JN

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $9.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,965.54, is for the supply of KEPPRA 500 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order, has no set-aside designation, and has an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEPPRA 500 mg tablets. The contract has a ceiling value of $10,453.67 and a performance period through June 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing...
This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4565047090 - KEPPRA 500 MG TABLET 120S. The contract has a ceiling value of $10,723.98 and a period of performance through July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Keppra, a medication used for the treatment of epilepsy, with a ceiling value of $1,749.96 and a period of performance through July 8, 2025. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a $4,504.98 firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 500 MG TABLET 120S, a neurological medication, with a period of performance through June 17, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX,...
This federal contract award, valued at $81,267.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 1,000 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of March 27, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Keppra 1,000 mg tablets. The contract has a ceiling value of $12,577.01 and a completion date of April 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,909.35, is for the delivery of 60 tablets of the prescription medication Keppra 1,000 mg. The ultimate completion date for this order is July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,599.00 firm fixed-price delivery order is for the supply of KEPPRA 500 MG TABLET 120S, a drug used to treat seizures. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen is a large, for-profit organization that specializes in distributing a wide range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 100 MG/ML ORAL SOLN 473ML, a prescription medication. The contract has a firm fixed price ceiling value of $10,941.59 and a period of performance that runs through July 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8JN
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEPPRA 500 MG TABLET 120S. The contract has a firm fixed price of $9,383.99 and a completion date of November 4, 2024. The contract is not designated as a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 2:05 PM